RecruitingNCT06572215

DYNAMic Renal Assessment: NOvel Methods to Assess KIDNEY Functional Reserve


Sponsor

King's College Hospital NHS Trust

Enrollment

44 participants

Start Date

Dec 14, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

This is a feasibility study to assess new, more practical ways of measuring renal reserve.


Eligibility

Min Age: 40 Years

Inclusion Criteria1

  • Patients with sickle cell nephropathy, diagnosed clinically or histologically. Sickle Cell patients will be confirmed Hb SS and eGFR (CKD-EPI) ≥ 135 ml/min/1.73m2 OR Previous living kidney donation Age ≥ 4No contraindication or known allergy to any trial medications. Willing and able to provide written informed consent

Exclusion Criteria1

  • Aged \< 40 Unable or unwilling to provide informed consent Breastfeeding or pregnant women Patients involved in other interventional research studies.

Interventions

DRUGDapagliflozin

On Day 3 to 16, participants will take 10mg dapaglifozin (SGLT-2 inhibitor) orally once daily.


Locations(1)

King's College Hospital

London, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06572215


Related Trials